Livagen 20mg
Synthetic Tetrapeptide Bioregulator | Laboratory Use Only
Livagen is a synthetic tetrapeptide (Lys-Glu-Asp-Ala, also written KEDA) from the Khavinson family of short-peptide bioregulators, developed at the St. Petersburg Institute of Bioregulation and Gerontology. It is supplied as a research tool for studying peptide-DNA and peptide-metal interactions, chromatin structure, and gene expression in cell-based and preclinical models.
$112.00
Availability: 10 in stock
Product Overview
- Compound: Livagen (Lys-Glu-Asp-Ala)
- Class: Short-chain tetrapeptide bioregulator
- Molecular formula and weight: C₁₈H₃₁N₅O₉, about 461.5 g/mol
- Common strengths: 10 mg or 20 mg per vial (confirm yours)
- Format: Lyophilized powder
- Purity: Typically ≥99% by HPLC, with mass spectrometry identity confirmation
- Documentation: Lot-specific Certificate of Analysis (COA)
Research Areas of Interest
- Chromatin structure and heterochromatin organization in cultured cells
- Gene expression and epigenetic regulation models
- Peptide-DNA and peptide-metal (for example, zinc) interaction studies
- Tissue-specific peptide pharmacology, including hepatic cell models
- Comparative studies with other Khavinson peptides such as Vesugen, Pancreagen, and Prostamax
